![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Vol. 18, Issue 6, 1965-1978, June 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
*Department of Immunology, School of Basic Medicine, and Human Disease Genomics Center, Peking University, Beijing 100083, China; and Shanghai Genomics, Inc., Shanghai 201203, China
Submitted July 18, 2006;
Revised February 13, 2007;
Accepted March 6, 2007
Monitoring Editor: J. Silvio Gutkind
PDCD10 (programmed cell death 10, TFAR15), a novel protein associated with cell apoptosis has been recently implicated in mutations associated with Cerebral Cavernous Malformations (CCM). Yeast two-hybrid screening revealed that PDCD10 interacts with MST4, a member of Ste20-related kinases. This interaction was confirmed by coimmunoprecipitation and colocalization assays in mammalian cells. Furthermore, the co-overexpression of PDCD10 and MST4 promoted cell proliferation and transformation via modulation of the extracellular signal-regulated kinase (ERK) pathway. Potent short interfering RNAs (siRNAs) against PDCD10 (siPDCD10) and MST4 (siMST4) were designed to specifically inhibit the expression of PDCD10 and MST4 mRNA, respectively. The induction of siPDCD10 or siMST4 resulted in decreased expression of endogenous PDCD10 or MST4, which was accompanied by reduced ERK activity and attenuated cell growth and anchorage-independent growth. On the other hand, siMST4 had similar effects in PDCD10-overexpressed cells. And more importantly, we confirmed that either overexpressing or endogenous PDCD10 can increase the MST4 kinase activity in vitro. Our results demonstrated that PDCD10 modulation of ERK signaling was mediated by MST4, and PDCD10 could be a regulatory adaptor necessary for MST4 function, suggesting a link between cerebral cavernous malformation pathogenesis and the ERK-MAPK cascade via PDCD10/MST4.
These authors contributed equally to this work.
Address correspondence to: Dalong Ma (madl{at}bjmu.edu.cn)
This article has been cited by other articles:
|
|
 |
|
  L. Chen, G. Tanriover, H. Yano, R. Friedlander, A. Louvi, and M. Gunel Apoptotic Functions of PDCD10/CCM3, the Gene Mutated in Cerebral Cavernous Malformation 3 Stroke, April 1, 2009; 40(4): 1474 - 1481. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Boulday, A. Blecon, N. Petit, F. Chareyre, L. A. Garcia, M. Niwa-Kawakita, M. Giovannini, and E. Tournier-Lasserve Tissue-specific conditional CCM2 knockout mice establish the essential role of endothelial CCM2 in angiogenesis: implications for human cerebral cavernous malformations Dis. Model. Mech., March 1, 2009; 2(3-4): 168 - 177. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Goudreault, L. M. D'Ambrosio, M. J. Kean, M. J. Mullin, B. G. Larsen, A. Sanchez, S. Chaudhry, G. I. Chen, F. Sicheri, A. I. Nesvizhskii, et al. A PP2A Phosphatase High Density Interaction Network Identifies a Novel Striatin-interacting Phosphatase and Kinase Complex Linked to the Cerebral Cavernous Malformation 3 (CCM3) Protein Mol. Cell. Proteomics, January 1, 2009; 8(1): 157 - 171. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. D. Stoner, A. A. Dombkowski, R. K. Reen, D. Cukovic, S. Salagrama, L.-S. Wang, and J. F. Lechner Carcinogen-Altered Genes in Rat Esophagus Positively Modulated to Normal Levels of Expression by Both Black Raspberries and Phenylethyl Isothiocyanate Cancer Res., August 1, 2008; 68(15): 6460 - 6467. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Rohlfs, R. Arasada, P. Batsios, J. Janzen, and M. Schleicher The Ste20-like kinase SvkA of Dictyostelium discoideum is essential for late stages of cytokinesis J. Cell Sci., December 15, 2007; 120(24): 4345 - 4354. [Abstract] [Full Text] [PDF]
|
|
